These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11369372)

  • 1. Fas expression and apoptosis in rats with experimental autoimmune uveoretinitis.
    Abe T; Nakajima A; Satoh N; Sakuragi S
    Jpn J Ophthalmol; 2001; 45(3):240-6. PubMed ID: 11369372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of apoptotic cells in experimental autoimmune uveoretinitis.
    Sueda J; Hikita N; Mochizuki M; Jimi A; Kojiro M
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):799-804. PubMed ID: 10711696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
    Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
    Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular cytokine quantification of experimental autoimmune uveoretinitis in rats.
    Okada AA; Sakai J; Usui M; Mizuguchi J
    Ocul Immunol Inflamm; 1998 Jun; 6(2):111-20. PubMed ID: 9689641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
    Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
    Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sex hormones on experimental autoimmune uveoretinitis (EAU).
    Buggage RR; Matteson DM; Shen DF; Sun B; Tuaillon N; Chan CC
    Immunol Invest; 2003 Nov; 32(4):259-73. PubMed ID: 14603994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas/Fas ligand-associated apoptosis in experimental autoimmune uveoretinitis in rodents: role of proinflammatory corticotropin-releasing hormone.
    Poulaki V; Mitsiades N; Mastorakos G; Caspi RR; Chrousos GP; Bouzas E
    Exp Eye Res; 2001 Jun; 72(6):623-9. PubMed ID: 11384150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
    Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
    Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of monoclonal antibodies directed at cell surface molecules on murine experimental autoimmune uveoretinitis.
    Ando K; Fujino Y; Mochizuki M
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):848-54. PubMed ID: 10502060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of interferon-beta suppresses experimental autoimmune uveoretinitis.
    Suzuki J; Sakai J; Okada AA; Takada E; Usui M; Mizuguchi J
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):314-21. PubMed ID: 11981647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in retina during development of experimental autoimmune uveoretinitis in rats.
    Watanabe T; Keino H; Kudo A; Sato Y; Okada AA
    Br J Ophthalmol; 2016 Mar; 100(3):425-31. PubMed ID: 26541434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of experimental ocular inflammation on ocular immune privilege.
    Ohta K; Wiggert B; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of actively induced experimental autoimmune uveoretinitis by CD4+ T cells.
    Uchio E; Kijima M; Ishioka M; Tanaka S; Ohno S
    Graefes Arch Clin Exp Ophthalmol; 1997 Feb; 235(2):97-102. PubMed ID: 9147958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of Rbpj attenuates experimental autoimmune uveoretinitis by inhibiting IL-22-producing CD4+ T cells.
    Bhuyan ZA; Asanoma M; Iwata A; Ishifune C; Maekawa Y; Shimada M; Yasutomo K
    PLoS One; 2014; 9(2):e89266. PubMed ID: 24586644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible co-stimulator (ICOS) is upregulated in experimental autoimmune uveoretinitis.
    Xing L; Yang P; Wu C; Jin H; Chen X; Gao Y; Li B; Huang X; Zhou H
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1650-8. PubMed ID: 16601981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the Notch signaling pathway disturbs the CD4
    Yin X; Liu B; Wei H; Wu S; Guo L; Xu F; Liu T; Bi H; Guo D
    Inflamm Res; 2019 Sep; 68(9):761-774. PubMed ID: 31209505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of experimental autoimmune uveoretinitis by Anti-IL-17 antibody.
    Zhang R; Qian J; Guo J; Yuan YF; Xue K
    Curr Eye Res; 2009 Apr; 34(4):297-303. PubMed ID: 19373578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.